Abciximab in Patients With Acute Myocardial Infarction: One Year Outcomes in the BRAVE-3 Randomized Trial

被引：0
|
作者：
Birkmeier, K. Anette
Mehilli, Julinda
Kastrati, Adnan
Schulz, Stefanie
Moshage, Werner
Dotzer, Franz
Pache, Juergen
Dirschinger, Josef
Seyfarth, Melchior
Schoemig, Albert
机构：
[1] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany
[2] 1 Med Klin Rechts Isar, Munich, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [1] One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial
    Schulz, Stefanie
    Birkmeier, K. Anette
    Ndrepepa, Gjin
    Moshage, Werner
    Dotzer, Franz
    Huber, Kurt
    Dirschinger, Josef
    Seyfarth, Melchior
    Schoemig, Albert
    Kastrati, Adnan
    Mehilli, Julinda
    CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (12) : 795 - 802
  • [2] One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial
    Stefanie Schulz
    K. Anette Birkmeier
    Gjin Ndrepepa
    Werner Moshage
    Franz Dotzer
    Kurt Huber
    Josef Dirschinger
    Melchior Seyfarth
    Albert Schömig
    Adnan Kastrati
    Julinda Mehilli
    Clinical Research in Cardiology, 2010, 99 : 795 - 802
  • [3] One-year outcome of the sevoflurane in acute myocardial infarction randomized trial
    Lavi, Shahar
    Alemayehu, Mistre
    McCarty, David
    Warrington, James
    Lavi, Ronit
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2015, 62 (12): : 1279 - 1286
  • [4] A multicenter international randomized trial comparing infarct artery stenting alone with infarct artery stenting plus abciximab in acute myocardial infarction: The abciximab and carbostent evaluation in acute myocardial infarction (ACE) trial. Final results and one-year outcome
    Antoniucci, D
    Rodriguez, A
    Hempel, A
    Valenti, R
    Migliorini, A
    Vigo, F
    Parodi, G
    Fernandez-Pereira, C
    Moschi, G
    Bartorelli, A
    Colombo, A
    CIRCULATION, 2003, 108 (17) : 578 - 578
  • [5] A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction
    Antoniucci, D
    Rodriguez, A
    Hempel, A
    Valenti, R
    Migliorini, A
    Vigo, F
    Parodi, G
    Fernandez-Pereira, C
    Moschi, G
    Bartorelli, A
    Santoro, GM
    Bolognese, L
    Colombo, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (11) : 1879 - 1885
  • [6] Differential benefit of abciximab as adjunctive to infarct artery stenting in patients with acute myocardial infarction: Insights from the abciximab and carbostent evaluation in acute myocardial infarction (ACE) trial
    Antoniucci, D
    Valenti, R
    Migliorini, A
    Parodi, G
    Moschi, G
    Santoro, GM
    Bolognese, L
    Rodriguez, A
    Vigo, F
    Femandez-Pereira, C
    Bartorelli, A
    Hempel, A
    Colombo, A
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 229L - 230L
  • [7] Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention -: A randomized controlled trial
    Kastrati, A
    Mehilli, J
    Schlotterbeck, K
    Dotzer, F
    Dirschinger, J
    Schmitt, C
    Nekolla, SG
    Seyfarth, M
    Martinoff, S
    Markwardt, C
    Clermont, G
    Gerbig, HW
    Leiss, J
    Schwaiger, M
    Schömig, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (08): : 947 - 954
  • [8] Clinical outcome of patients with acute myocardial infarction randomized to either coronary stenting plus abciximab or fibrinolysis plus abciximab (STOPAMI-2 trial)
    Schoemig, A
    Kastrati, A
    Mehilli, J
    Dirschinger, J
    Schricke, U
    Neverve, J
    Pache, J
    Martinoff, S
    Neumann, FJ
    Nekolla, S
    Blasini, R
    Seyfarth, M
    Schwaiger, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 295A - 296A
  • [9] Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction:: a randomised trial
    Kastrati, A
    Mehilli, J
    Dirschinger, J
    Schricke, U
    Neverve, J
    Pache, J
    Martinoff, S
    Neumann, FJ
    Nekolla, S
    Blasini, R
    Seyfarth, M
    Schwaiger, M
    Schömig, A
    LANCET, 2002, 359 (9310): : 920 - 925
  • [10] Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials
    Kandzari, DE
    Hasselblad, V
    Tcheng, JE
    Stone, GW
    Califf, RM
    Brener, SJ
    Montalescot, G
    Neumann, FJ
    Kastrati, A
    Harrington, RA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 333A - 333A
12345